APA

Messingerová L., Jonášová A., Barančik M., Poleková L., Šereš M., Gibalová L., Breier A. & Sulová Z. (20160223). Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome. : General physiology and biophysics.

Chicago

Messingerová Lucia, Jonášová Anna, Barančik Miroslav, Poleková Lenka, Šereš Mário, Gibalová Lenka, Breier Albert and Sulová Zdena. 20160223. Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome. : General physiology and biophysics.

Harvard

Messingerová L., Jonášová A., Barančik M., Poleková L., Šereš M., Gibalová L., Breier A. and Sulová Z. (20160223). Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome. : General physiology and biophysics.

MLA

Messingerová Lucia, Jonášová Anna, Barančik Miroslav, Poleková Lenka, Šereš Mário, Gibalová Lenka, Breier Albert and Sulová Zdena. Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome. : General physiology and biophysics. 20160223.